Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/6223
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDuvar, H.-
dc.contributor.authorŞengül, Cem-
dc.contributor.authorHerken, Hasan-
dc.date.accessioned2019-08-16T12:05:08Z
dc.date.available2019-08-16T12:05:08Z
dc.date.issued2010-
dc.identifier.issn1304-3889-
dc.identifier.urihttps://hdl.handle.net/11499/6223-
dc.description.abstractThough it has been known for a long time, due to the fact that the controlled studies are limited and the disorder is uncommon, case reports have been important supporting the data of the treatments. In general, depending on whether the patient used drug before and considering the effects and side effects of the drugs the first choice in the treatment is antipsychotic drugs. New atypical antipsychotic agents are preferred for their relatively less side effects and higher drug adaptation. We aimed to report a case of delusional disorder (jealous type) which did not respond to different atypical antipsychotic agents previously but shows a prognostic improvement by aripiprazole of 30mg/day. Aripiprazole may be an effective option for the treatment of delusional disorder, with few side effects, high drug compliance and efficacy.en_US
dc.language.isotren_US
dc.relation.ispartofEuropean Journal of General Medicineen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAripiprazoleen_US
dc.subjectDelusional disorderen_US
dc.subjectTreatmenten_US
dc.subjectaripiprazoleen_US
dc.subjectolanzapineen_US
dc.subjectrisperidoneen_US
dc.subjectsertralineen_US
dc.subjectvenlafaxineen_US
dc.subjectadulten_US
dc.subjectarticleen_US
dc.subjectblood cell counten_US
dc.subjectcase reporten_US
dc.subjectcomputer assisted tomographyen_US
dc.subjectdelusional disorderen_US
dc.subjectdrug dose titrationen_US
dc.subjectdrug efficacyen_US
dc.subjectdrug withdrawalen_US
dc.subjectextrapyramidal symptomen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectmajor depressionen_US
dc.subjectnuclear magnetic resonance imagingen_US
dc.subjectpatient complianceen_US
dc.subjectprognosisen_US
dc.subjectpsychomotor retardationen_US
dc.subjectrigidityen_US
dc.subjectside effecten_US
dc.subjecttremoren_US
dc.subjectunspecified side effecten_US
dc.subjectweight gainen_US
dc.titleAripiprazole in delusional disorderen_US
dc.typeArticleen_US
dc.identifier.volume7en_US
dc.identifier.issue4en_US
dc.identifier.startpage433
dc.identifier.startpage433en_US
dc.identifier.endpage435en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-78650925863en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale University-
item.cerifentitytypePublications-
item.languageiso639-1tr-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.openairetypeArticle-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Files in This Item:
File SizeFormat 
aripiprazole-in-delusional-disorder-6822.pdf263.04 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

5
checked on Nov 16, 2024

Page view(s)

44
checked on Aug 24, 2024

Download(s)

22
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.